Global Pharmaceutical Gelatin Market Assessment, By Type [Type A, Type B], By Source [Bovine, Porcine, Others], By Application [Hard Gelatin Capsules, Soft Gelatin Capsules, Others], By Function [Stabilizing, Thickening, Gelling and Others], By End-user [Pharmaceutical Companies, Biotechnology Companies, Academic and Research Institutions], By Region, Opportunities and Forecast, 2017-2031F
The pharmaceutical gelatin market is expected to grow because of an increased focus on technological advancements and the increasing popularity of gelatin-based soft gels and hard gelatin capsules.
Home>Industry Reports>Global Pharmaceutical Gelatin Market Assessment, Opportunities and Forecast, 2017-2031F
Global pharmaceutical gelatin market is projected to witness a CAGR of 5.57% during the forecast period 2024-2031F, growing from USD 1.25 billion in 2023 to USD 1.92 billion in 2031F. Various factors shape the global pharmaceutical gelatin market. These include increased investments in research, technological advancements, high demand for porcine gelatin, rise in the popularity of gelatin capsules, growing demand in the European market, and companies increasingly seeking expansion opportunities.
One significant driver of the global pharmaceutical gelatin market is the increased investment in research and development initiatives. These initiatives aid in promoting innovation and technological advancements in the industry, which is required for growth and increased production. Gelatin is finding new uses in pharmaceuticals thanks to technological developments in drug delivery and gelatin-based therapeutics. The high demand for porcine gelatin is another major factor driving the growth of the global pharmaceutical gelatin market. The superior qualities of porcine gelatin make it extremely desirable for use in the pharmaceutical industry. The applications of porcine gelatin are increasing with advancements in technologies, which indicates its continued demand for the product in the future.
Advancements are improving the performance and adaptability of gelatin capsules in capsule technology, such as the creation of plant-based gelatin capsules, which is increasing their appeal to both producers and customers. Gelatin capsules are in high demand in the global pharmaceutical gelatin market because of their ability to protect the contents from air, light, microbial growth and contamination. The European market is an additional significant factor boosting the growth of the global pharmaceutical gelatin market. Pharmaceutical gelatin is becoming more and more essential due to the European Union's growing pharmaceutical market and strong pharmaceutical sector.
Finally, businesses seek variety and growth. The introduction of new gelatin brands and the growth of established ones into new areas are clear indications of this. These factors are anticipated to fuel the further growth and diversification of the global pharmaceutical gelatin market in the upcoming years.
For example, in May 2024, the Kerala State Industrial Development Corporation Ltd (KSIDC) and Nitta Gelatin Inc. Japan jointly launched an expansion project in Kerala valued at USD 7.18 million through Nitta Gelatin India Ltd (NGIL). This project is a portion of the USD 23.96 million investment that the Japanese MNC disclosed during the Kerala Chief Minister's most recent visit to Japan.
Research Initiatives Propel the Expansion of the Market
Due to the industry's growing research and development (R&D) activities, the global pharmaceutical gelatin market is expanding significantly on a large scale. Pharmaceutical corporations are heavily spending on research and development to create cutting-edge gelatin-based products like biodegradable capsules and sophisticated drug delivery systems. New gelatin brands and products have emerged as a result, such as X-Pure-GelDAT, a substitute for GelTYR-Gelatin Tyramine. Furthermore, it is anticipated that developments in gelatin production methods will boost productivity and affordability, propelling the expansion of the global pharmaceutical gelatin market.
For example, in January 2022, Darling Ingredients Inc. established a partnership with the Terasaki Institute for Biomedical Innovation (TIBI), a regenerative medicine research institute situated in California, through its Rousselot Health brand, which is the world leader in collagen-based solutions. Rousselot and TIBI will work together on the creation of gelatin-based treatments and their clinical application through this strategic alliance. Rousselot will provide TIBI with X-Pure modified gelatins, including X-Pure GelMA, in exchange for information on how gelatin behaves in the laboratory and throughout clinical trials.
Technological Advancements Spur Growth of the Market
Advancements in technologies such as nanotechnology, 3D printing, artificial intelligence, and machine learning are propelling the growth of the global pharmaceutical gelatin market. Pharmaceutical companies are making use of these technologies to produce novel gelatin-based goods that surpass the functionality and quality of conventional solutions. These technologies have made the development process of gelatin-based products more cost-effective and efficient. Gelatin is also being extensively used in other pharmaceutical sectors such as gene therapy, drug delivery systems, and tissue engineering. The application of gelatin in the pharmaceutical industry will continue to expand due to these technologies propelling the growth of the global pharmaceutical gelatin market.
For example, in December 2023, the health brand Rousselot from Darling Ingredients Inc. announced that it had received US Patent and Trademark Office (USPTO) Patent No. US11795489B2, securing its intellectual property rights for StabiCaps, a specialized gelatin that enhances the stability and formulation of soft gel capsules to improve drugs' release.
High Demand for Porcine Gelatin Drives Market Growth
Due to the unique characteristics of gel-forming ability and the biocompatible nature of porcine gelatin, it is commonly used in the pharmaceutical industry, bolstering the growth of the global pharmaceutical gelatin market. Porcine gelatin is known for its clarity and flexibility, which makes it excessively useful in the manufacturing of hard gelatin capsules, and it also has other applications in the pharmaceutical industry, such as soft capsules, absorbable hemostats, etc. It is also used as a stabilizer in vaccines to preserve its efficacy and safety throughout the transit and storage process. Porcine gelatin is a preferred choice for pharmaceutical manufacturers because of its ease of production, nutritious content, and reduced cost.
For instance, to save production costs and waste related to soft gel leakers, Gelita AG, a global leader in gelatin, introduced Easyseal gelatin in December 2023. The novel solution can be obtained in swine form that complies with food and drug administration (FDA) requirements, and a corresponding China Drug Masterfile is available to facilitate entry into the Chinese market.
Rise in the Popularity of Gelatin Capsules Fuels Market Growth
There is a huge demand for gelatin capsules because of their versatility and ease of use. A significant demand for dietary supplements and nutraceuticals has been seen in the last few years, boosting the growth of gelatin capsules in the global pharmaceutical gelatin market. There is an increased demand for gelatin capsules made from alternative sources because of the rise in inclination towards vegan lifestyles and plant-based food. Gelatin capsules are becoming more customizable and effective due to technological and formulation advances, which appeal to both manufacturers and consumers.
In September 2023, Strides Pharma Science Limited declared that the United States Food and Drug Administration (USFDA) has approved Icosapent Ethyl Capsules, 0.5 gram and 1 gram, through its step-down wholly owned subsidiary, Strides Pharma Global Pte, Singapore. The product enhances the selection of authorized soft gelatin capsules offered by Strides.
Europe Shows Dominance in the Pharmaceutical Gelatin Market
Europe's pharmaceutical gelatin market has observed significant growth over the past couple of years. Companies are focusing on producing new products through research and development to cater to the growing demand that has arisen because of the growing burden of chronic diseases and the rise in the geriatric population. The global pharmaceutical gelatin market participants focus on continuous clinical trials to improve the efficacy of the medications. The global pharmaceutical gelatin market is expanding due to pharmaceutical companies and concerned authorities meeting patient requirements, surpassing challenges such as the limitations of sustainability and ethical concerns.
For example, Caldic B.V. and Nitta Gelatin, Inc. announced that they had reached an agreement to form a strategic distribution relationship in Europe. Through this partnership, Caldic will be able to provide a greater selection of specialty gelatin products and a broad range of collagen products that perfectly match its current line of products for the Food, Nutrition, Pharma, and Personal Care markets. Starting on January 1, 2024, Caldic and Nitta Gelatin collaborated to create prospects in Benelux, France, Iberia, Italy, Germany, Austria, Switzerland, United Kingdom, and Ireland.
Future Market Scenario (2024-2031F)
1. The significant shift toward biodegradable gelatin capsules is considered a major factor driving the growth of the global pharmaceutical gelatin market in the future.
2. The global pharmaceutical gelatin market will witness a significant rise in the use of gelatin in the functional food industry.
3. Advanced technologies like nanotechnology and 3D printing are going to drive the global pharmaceutical gelatin market. These technologies are used to produce innovative gelatin products with enhanced properties.
4. An increased use of gelatin in cosmetics and personal care products is expected to significantly drive the growth of the global pharmaceutical gelatin market.
Report Scope
“Pharmaceutical Gelatin Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, that provides an in-depth analysis and qualitative and quantitative assessment of the current state of the global pharmaceutical gelatin market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecasts between 2024 and 2031F. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031F |
|
Projected Growth Rate |
CAGR of 5.57% between 2024 and 2031F |
|
Revenue Forecast in 2031 |
USD 1.92 billion |
|
Segments Covered |
Type, Source, Application, Function, End-user |
|
Regions Covered |
North America, Europe, South America, Asia-Pacific, Middle East and Africa |
|
Key Companies Profile |
Gelita AG, Darling Ingredients Inc., Nitta Gelatin, Inc., Tessenderlo Group, Weishardt International, Lonza Group AG, Aspire Pharmaceuticals, Inc., Junca Gelatines S.L, Gelco International, Trobas Gelatine BV |
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfill your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, the global pharmaceutical gelatin market has been segmented into the following categories:
- By Type
- Type A
- Type B
- By Source
- Bovine
- Porcine
- Others
- By Application
- Hard Gelatin Capsules
- Soft Gelatin Capsules
- Others
- By Function
- Stabilizing
- Thickening
- Gelling
- Others
- By End-user
- Pharmaceutical Companies
- Biotechnology Companies
- Academic and Research Institutions
- By Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
Key Players Landscape and Outlook
One of the main factors driving the expansion of the global pharmaceutical gelatin market is partnerships and collaborations. These partnerships guarantee that many viewpoints are considered to meet the needs of a diversified nature. Through successful collaborations, companies in the industry share their expertise in developing new and innovative solutions, increasing efficiency, and reducing costs. Companies also often collaborate to increase their expansion in the global pharmaceutical gelatin market and reach new customers.
For example, in March 2024, BIO INX B.V., a leading material developer for 3D bioprinting, announced a strategic relationship with Rousselot GmbH, a global leader in gelatin- and collagen-based solutions included in Darling Ingredients Inc. This partnership represents a significant advancement in the field of 3D bioprinting. As part of this partnership, Rousselot's X-Pure gelatin biomaterials, which are known for their dependability and quality, will be distributed by BIO INX for research and technical purposes.
Key Players Operating in the Global Pharmaceutical Gelatin Market are:
- Gelita AG
- Darling Ingredients Inc.
- Nitta Gelatin, Inc.
- Tessenderlo Group
- Weishardt International
- Lonza Group AG
- Aspire Pharmaceuticals, Inc.
- Junca Gelatines S.L.
- Gelco International
- Trobas Gelatine BV
Markets and Data’s reports answer the following questions:
- What is the current and future market size of the product/service in question globally or specific to different countries?
- How are the markets divided into different product/service segments and the market size and growth of each segment?
- What is the market potential of different product segments and their investment case?
- How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
- What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for the global pharmaceutical gelatin market, you may approach our team at info@marketsandata.com.
Table of Contents
1. Research Methodology
2. Project Scope and Definitions
3. Executive Summary
4. Global Pharmaceutical Gelatin Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.By Value
4.1.2.By Volume
4.2. By Type
4.2.1.Type A
4.2.2.Type B
4.3. By Source
4.3.1.Bovine
4.3.2.Porcine
4.3.3.Others
4.4. By Application
4.4.1.Hard Gelatin Capsules
4.4.2.Soft Gelatin Capsules
4.4.3.Others
4.5. By Function
4.5.1.Stabilizing
4.5.2.Thickening
4.5.3.Gelling
4.5.4.Others
4.6. By End-user
4.6.1.Pharmaceutical Companies
4.6.2.Biotechnology Companies
4.6.3.Academic and Research Institutions
4.7. By Region
4.7.1.North America
4.7.2.Europe
4.7.3.Asia-Pacific
4.7.4.South America
4.7.5.Middle East and Africa
4.8. By Company Market Share (%), 2023
5. Global Pharmaceutical Gelatin Market Outlook, By Region, 2017-2031F
5.1. North America*
5.1.1.Market Size & Forecast
5.1.1.1. By Value
5.1.1.2. By Volume
5.1.2.By Type
5.1.2.1. Type A
5.1.2.2. Type B
5.1.3.By Source
5.1.3.1. Bovine
5.1.3.2. Porcine
5.1.3.3. Others
5.1.4.By Application
5.1.4.1. Hard Gelatin Capsules
5.1.4.2. Soft Gelatin Capsules
5.1.4.3. Others
5.1.5.By Function
5.1.5.1. Stabilizing
5.1.5.2. Thickening
5.1.5.3. Gelling
5.1.5.4. Others
5.1.6.By End-user
5.1.6.1. Pharmaceutical Companies
5.1.6.2. Biotechnology Companies
5.1.6.3. Academic and Research Institutions
5.1.7.United States*
5.1.7.1. Market Size & Forecast
5.1.7.1.1. By Value
5.1.7.1.2. By Volume
5.1.7.2. By Type
5.1.7.2.1. Type A
5.1.7.2.2. Type B
5.1.7.3. By Source
5.1.7.3.1. Bovine
5.1.7.3.2. Porcine
5.1.7.3.3. Others
5.1.7.4. By Application
5.1.7.4.1. Hard Gelatin Capsules
5.1.7.4.2. Soft Gelatin Capsules
5.1.7.4.3. Others
5.1.7.5. By Function
5.1.7.5.1. Stabilizing
5.1.7.5.2. Thickening
5.1.7.5.3. Gelling
5.1.7.5.4. Others
5.1.7.6. By End-user
5.1.7.6.1. Pharmaceutical Companies
5.1.7.6.2. Biotechnology Companies
5.1.7.6.3. Academic and Research Institutions
5.1.8.Canada
5.1.9.Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. Asia-Pacific
5.3.1.India
5.3.2.China
5.3.3.Japan
5.3.4.Australia
5.3.5.Vietnam
5.3.6.South Korea
5.3.7.Indonesia
5.3.8.Philippines
5.4. South America
5.4.1.Brazil
5.4.2.Argentina
5.5. Middle East and Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.South Africa
6. Market Mapping, 2023
6.1. By Type
6.2. By Source
6.3. By Application
6.4. By Function
6.5. By End-user
6.6. By Region
7. Macro Environment and Industry Structure
7.1. Demand Supply Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
7.4.1.Political Factors
7.4.2.Economic System
7.4.3.Social Implications
7.4.4.Technological Advancements
7.4.5.Environmental Impacts
7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1.Supplier Power
7.5.2.Buyer Power
7.5.3.Substitution Threat
7.5.4.Threat From New Entrant
7.5.5.Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
9.1. Patent Landscape
9.2. Regulatory Approvals
9.3. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. Gelita AG
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products and Services
13.1.4. Financials (As Reported)
13.1.5. Key Market Focus and Geographical Presence
13.1.6. Recent Developments
13.2. Darling Ingredients Inc.
13.3. Nitta Gelatin, Inc.
13.4. Tessenderlo Group
13.5. Weishardt International
13.6. Lonza Group AG
13.7. Aspire Pharmaceuticals, Inc.
13.8. Junca Gelatines S.L
13.9. Gelco International
13.10. Trobas Gelatine BV
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.
14. Strategic Recommendations
15 . About Us & Disclaimer
List of Figures
Figure 1. Global Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 3. Global Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 4. Global Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 5. Global Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 6. Global Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 7. Global Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 8. Global Pharmaceutical Gelatin Market Share (%), By Region, 2017-2031F
Figure 9. North America Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 10. North America Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 11. North America Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 12. North America Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 13. North America Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 14. North America Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 15. North America Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 16. North America Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
Figure 17. United States Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 18. United States Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 19. United States Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 20. United States Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 21. United States Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 22. United States Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 23. United States Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 24. Canada Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 25. Canada Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 26. Canada Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 27. Canada Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 28. Canada Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 29. Canada Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 30. Canada Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 31. Mexico Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 32. Mexico Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 33. Mexico Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 34. Mexico Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 35. Mexico Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 36. Mexico Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 37. Mexico Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 38. Europe Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 39. Europe Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 40. Europe Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 41. Europe Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 42. Europe Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 43. Europe Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 44. Europe Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 45. Europe Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
Figure 46. Germany Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 47. Germany Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 48. Germany Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 49. Germany Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 50. Germany Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 51. Germany Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 52. Germany Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 53. France Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 54. France Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 55. France Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 56. France Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 57. France Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 58. France Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 59. France Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 60. Italy Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 61. Italy Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 62. Italy Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 63. Italy Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 64. Italy Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 65. Italy Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 66. Italy Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 67. United Kingdom Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 68. United Kingdom Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 69. United Kingdom Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 70. United Kingdom Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 71. United Kingdom Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 72. United Kingdom Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 73. United Kingdom Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 74. Russia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 75. Russia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 76. Russia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 77. Russia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 78. Russia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 79. Russia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 80. Russia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 81. Netherlands Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 82. Netherlands Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 83. Netherlands Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 84. Netherlands Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 85. Netherlands Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 86. Netherlands Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 87. Netherlands Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 88. Spain Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 89. Spain Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 90. Spain Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 91. Spain Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 92. Spain Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 93. Spain Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 94. Spain Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 95. Turkey Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 96. Turkey Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 97. Turkey Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 98. Turkey Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 99. Turkey Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 100. Turkey Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 101. Turkey Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 102. Poland Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 103. Poland Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 104. Poland Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 105. Poland Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 106. Poland Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 107. Poland Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 108. Poland Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 109. South America Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 110. South America Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 111. South America Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 112. South America Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 113. South America Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 114. South America Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 115. South America Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 116. South America Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
Figure 117. Brazil Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 118. Brazil Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 119. Brazil Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 120. Brazil Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 121. Brazil Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 122. Brazil Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 123. Brazil Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 124. Argentina Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 125. Argentina Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 126. Argentina Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 127. Argentina Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 128. Argentina Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 129. Argentina Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 130. Argentina Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 131. Asia-Pacific Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 132. Asia-Pacific Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 133. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 134. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 135. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 136. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 137. Asia- Pacific Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 138. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
Figure 139. India Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 140. India Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 141. India Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 142. India Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 143. India Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 144. India Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 145. India Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 146. China Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 147. China Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 148. China Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 149. China Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 150. China Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 151. China Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 152. China Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 153. Japan Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 154. Japan Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 155. Japan Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 156. Japan Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 157. Japan Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 158. Japan Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 159. Japan Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 160. Australia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 161. Australia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 162. Australia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 163. Australia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 164. Australia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 165. Australia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 166. Australia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 167. Vietnam Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 168. Vietnam Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 169. Vietnam Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 170. Vietnam Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 171. Vietnam Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 172. Vietnam Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 173. Vietnam Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 174. South Korea Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 175. South Korea Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 176. South Korea Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 177. South Korea Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 178. South Korea Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 179. South Korea Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 180. South Korea Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 181. Indonesia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 182. Indonesia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 183. Indonesia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 184. Indonesia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 185. Indonesia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 186. Indonesia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 187. Indonesia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 188. Philippines Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 189. Philippines Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 190. Philippines Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 191. Philippines Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 192. Philippines Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 193. Philippines Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 194. Philippines Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 195. Middle East & Africa Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 196. Middle East & Africa Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 197. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 198. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 199. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 200. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 201. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 202. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
Figure 203. Saudi Arabia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 204. Saudi Arabia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 205. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 206. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 207. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 208. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 209. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 210. UAE Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 211. UAE Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 212. UAE Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 213. UAE Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 214. UAE Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 215. UAE Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 216. UAE Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 217. South Africa Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 218. South Africa Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 219. South Africa Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 220. South Africa Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 221. South Africa Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 222. South Africa Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 223. South Africa Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 224. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 225. By Source Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227. By Function Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228. By End-User Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
What regions are covered in the final report for the global pharmaceutical gelatin market?
What are the major drivers influencing the growth of the global pharmaceutical gelatin market?
Who are the key players operating in the global pharmaceutical gelatin market?
What is the market size and growth rate of the global pharmaceutical gelatin market?
See Related Reports
Global Light Commercial Vehicle Tire Market Assessment, Opportunities and Forecast, 2017-2031F
Global light commercial vehicle tire market is projected to grow due to the growing e-commerce sector, flooding logistics activities, and rising number of multiple infrastructural projects.....Read More
Published on
July 2024
4,500
Global Mobile and Tablet Case Market Assessment, Opportunities and Forecast, 2017-2031F
Global mobile and tablet case market is anticipated to grow due to its utility in protection against physical damages, addition of water and dust resistance properties and introduction of stylish and quirky designs with durable materials to cater to ....Read More
Published on
July 2024
4,500
Global Pea Protein Market Assessment, Opportunities and Forecast, 2017-2031F
Global pea protein market is witnessing expansion due to consumers’ shift towards plant-based proteins.....Read More
Published on
July 2024
4,500
Global Soup Market Assessment, Opportunities and Forecast, 2017-2031F
Global soup market is witnessing expansion due to its longer shelf life and convenience in consumption.....Read More
Published on
July 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
